Initial Depression and Response to Imipramine in Agoraphobia
- 1 June 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Nervous & Mental Disease
- Vol. 175 (6) , 358-361
- https://doi.org/10.1097/00005053-198706000-00006
Abstract
Thirty-seven patients participating in a controlled treatment study with imipramine were classified as high or low depressed simultaneously on two depression measures. Analysis of variance by 2 (high-low depressed) .times. 2 (high-low imipramine dosage) groupings revealed significant dose but no depression main effects. The greater dose effect observed in the low depressed group and the greater response rates found among high-dose patients with low initial depression strongly suggest that the beneficial effect of imipramine in agoraphobia was not primarily antidepressant in nature.This publication has 8 references indexed in Scilit:
- AGORAPHOBIA - RELATIVE AND COMBINED EFFECTIVENESS OF THERAPIST-ASSISTED INVIVO EXPOSURE AND IMIPRAMINE1986
- Imipramine in the treatment of agoraphobia: dose-response relationshipsAmerican Journal of Psychiatry, 1985
- Panic attacks and the dexamethasone suppression testAmerican Journal of Psychiatry, 1983
- Dexamethasone suppression tests in patients with panic disorderAmerican Journal of Psychiatry, 1983
- The dexamethasone suppression test in panic disorder and agoraphobiaAmerican Journal of Psychiatry, 1982
- Brief standard self-rating for phobic patientsBehaviour Research and Therapy, 1979
- A Self-Rating Depression ScaleArchives of General Psychiatry, 1965
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961